The Rita Allen Foundation has awarded millions of dollars in grants to our Scholars. The Rita Allen Foundation Scholars program concentrates on young leaders in bio-medical research who are advancing our understanding of the human condition. Through our Scholars, we embrace innovative research with above average risk and groundbreaking possibilities. We are proud of the more than 140 Scholars, including a Nobel Laureate, who have received our financial assistance. Our Scholars are nominated by premier research institutions and then selected by the Rita Allen Foundation Scientific Advisory Committee. Individuals chosen and their affiliated institutions receive grants of up to $110,000 annually, for a maximum of five years. Some of the Guiding Principles for selection include: attention to innovation, focus on areas of global concern, opportunities for lasting outcomes, collaborations, and a demonstration of leadership and learning potential. Investment in our Scholars helps us support transformative ideas in their earliest stages.
|1976-80||James B. Lewis||Cold Spring Harbor|
|1976-78||Harold M. Weintraub||Princeton & Hutchinson Cancer Center|
|1976-79||Robert A. Weinberg||MIT|
|1978-82||Kathleen M. Foley||Cornell Medical|
|1978-81,86||William W. Hall||Rockefeller University|
|1978-79||Thomas P. Maniatis||Cal Tech|
|1978-82||Graham C. Walker||MIT|
|1979-83||John Condeelis||Albert Einstein College of Medicine|
|1979-83||Stephen A. Udem||Albert Einstein College of Medicine|
|1979-83||Paul H. Patterson||Harvard Medical|
|1983-87||Bruce W. Stillman||Cold Spring Harbor|
|1983-84||Luis P. Villarreal||Univ. of Colorado School of Medicine|
|1983-86||Barbara J. Wold||Cal Tech|
|1984-85||Thomas M. Jessell||Harvard Medical|
|1984-85||Carl F. Nathan||Rockefeller University|
|1984-88||H. Earl Ruley||MIT|
|1985-89||Bruce P. Bean||Harvard Medical|
|1985-89||Brent H. Cochran||MIT|
|1985-88||Stanley M. Goldin||Harvard Medical|
|1985-89||Winship Herr||Cold Spring Harbor|
|1985-87||Carl S. Parker||Cal Tech|
|1986-90||Ronald D.C. McKay||MIT|
|1986-90||Adrienne A. Brian||Univ. of California, San Diego|
|1986-90||Charles D. Gilbert||Rockefeller University|
|1988-92||Gilbert Chu||Stanford Medical Center|
|1988-92||Stephen L. Hauser||Univ. of California, San Francisco, Harvard|
|1988-92||Jon D. Levine||Univ. of California, San Francisco|
|1989-93||Andrew Z. Fire||Carnegie Institute of Washington|
|1989-93||Nouria Hernandez||Cold Spring Harbor|
|1989-92||Ronald D. Vale||Univ. of California, San Francisco|
|1990-91||Peter S. Kim||Whitehead Institute|
|1990-94||Greg Lemke||The Salk Institute|
|1990-94||Marilyn D. Resh||Princeton & Memorial Sloan-Kettering|
|1991-95||Jeffrey D. Macklis||Harvard Medical|
|1991-95||David O. Morgan||Univ. of California, San Francisco|
|1991-95||Elizabeth A. Komives||Univ. of California, San Diego|
|1993-97||Stephen L. Mayo||Cal Tech|
|1993-97||Christopher Walsh||Harvard Medical|
|1994-98||Michael O. Hengartner||Cold Spring Harbor|
|1994-98||Joachim J. Li||Univ. of California, San Francisco|
|1994-97||James R. Williamson||MIT & Scripps Research Institute|
|1995-99||Bruce A. Edgar||Fred Hutchinson Cancer Center|
|1995-99||Stephen P. Bell||MIT|
|1995-98||Titia de Lange||Rockefeller University|
|1996-99||Robert K. Ho||Princeton|
|1996-99||Li-Huei Tsai||Harvard Medical|
|1998-00||Peter Mombaerts||Rockefeller University|
|1998-00||Jon S. Thorson||Sloan-Kettering Institute|
|1998-00||Frank J. Hsu||Yale School of Medicine|
|1998-00||Ilaria Rebay||MIT-Whitehead Institute|
|1999-01||Susan M. Dymecki||Harvard Medical|
|1999-01||K. Christopher Garcia||Stanford School of Medicine|
|1999-01||Scott W. Lowe||Cold Spring Harbor|
|2000-02||Yukiko Goda||Univ. of CA, San Diego & Medical Research Council|
|2000-02||Michael P. Rout||Rockefeller University|
|2000-02||Gregory J. Hannon||Cold Spring Harbor|
|2001-03||Daniel L. Minor, Jr.||Univ. of CA., San Francisco|
|2001-03||Steven Artandi||Stanford University Medical Center|
|2001-03||Adrian R. Ferre-D’Amare||Fred Hutchinson Cancer Research Center|
|2001-03||Oliver Hobert||Columbia University|
|2001-03||David C. Chan||Cal Tech|
|2002-03||Mark Henkemeyer||Univ. of Texas, SW Medical Center|
|2002-04||Xianxin Hua||Univ. of PA Medical School|
|2002-03||Hao Wu||Cornell/Weill Medical School|
|2003-05||Christopher Lima||Cornell/Weill Medical College|
|2003-05||Shai Shaham||Rockefeller University|
|2003-05||Leslyn A. Hanakahi||Johns Hopkins|
|2004-07||Laura A. Johnston||Columbia University|
|2004-07||Senthil K. Muthuswamy||Cold Spring Harbor Laboratory|
|2004-07||David M. Sabatini||Whitehead Institute|
|2004-05||David A. Tuveson||University of Pennsylvania|
|2004-07||Zheng Zhou||Baylor College of Medicine|
|2005-09||Hilary A. Coller*||Princeton University|
|2005-09||Elsa R. Flores||MD Anderson Cancer Center|
|2005-08||Johanna Joyce||Memorial Sloan-Kettering|
|2005-09||Joel L. Pomerantz||Johns Hopkins School of Medicine|
|2006-10||Peter W. Reddien*||MIT-Whitehead Institute|
|2006-10||Joshua T. Mendell||Johns Hopkins School of Medicine|
|2006-10||Adrian Salic||Harvard Medical School|
|2007-10||Michael T. Hemann||MIT Center for Cancer Research|
|2007-10||Tae Hoon Kim||Yale University|
|2007-10||Lloyd C. Trotman||Cold Spring Harbor Laboratory|
|2007-10||Mark J. Zylka *||University of North Carolina at Chapel Hill|
|2008-11||E. Alejandro Sweet-Cordero||Stanford University Medical School|
|2008-11||Emmanuelle A. Passegue||University of California, San Francisco|
|2008-11||Ian J. Davis||University of North Carolina at Chapel Hill|
|2008-11||Paul Chang||MIT Cancer Research Center|
|2008-11||Ming Li||Memorial Sloan-Kettering Cancer Center|
|2008-13||Steven J. Altschuler *||University of Texas, Southwestern Medical Center|
|2009-12||Aaron D. Gitler||University of Pennsylvania|
|2009-14||Ben Black||University of Pennsylvania|
|2009-||Jeremy Dittman||Weill Cornell Medical College|
|2009-14||Samara Reck-Peterson *||Harvard Medical School|
|2009-14||Daniel Stetson||University of Washington School of Medicine|
|2009-14||Sohail Tavazoie||Rockefeller University|
|2009-12||Steven Prescott||University of Pittsburgh|
|2009-12||Theodore Price||University of Arizona|
|2010-||Randy Bruno||Columbia University|
|2010-||Maitreya Dunham||University of Washington|
|2010-||David Prober *||California Institute of Technology|
|2010-||Agata Smogorzewska||Rockefeller University|
|2010-||Ye Zheng||Salk Institute for Biological Studies|
|2010-13||Seena Ajit||Drexel University|
|2011-||Briana Burton*||Harvard University|
|2011-||Elissa Hallem||University of California, Los Angeles|
|2011-||Rahul Kohli||University of Pennsylvania|
|2011-||Michael Lin||Stanford University|
|2011-||Axel Nimmerjahn||Salk Institute for Biological Studies|
|2011-14||Edgar Romero-Sandoval||Dartmouth Hitchcock|
|2011-14||Yuanxiang Tao||Johns Hopkins University School of Medicine|
|2012-||Sreekanth Chalasani||Salk Institute for Biological Studies|
|2012-||Christopher Hammell *||Cold Spring Harbor Laboratory|
|2012-||Michael Jankowski||Cincinnati Children’s Hospital Medical Center|
|2012-||Xin Liu||UT Southwestern Medical Center|
|2012-||Michael Long||NYU School of Medicine|
|2012-||Luciano Marraffini||The Rockefeller University|
|2012-||Sarah Ross||University of Pittsburgh School of Medicine|
|2013-||Michael Boyce||Duke University School of Medicine|
|2013-||Sophie Dumont *||University of California, San Francisco|
|2013-||Dorothea Fiedler||Princeton University|
|2013-||Elena Gracheva||Yale School of Medicine|
|2013-||William James Greenleaf||Stanford University School of Medicine|
|2013-||Rebecca Seal||University of Pittsburgh|
|2013-||Reza Sharif-Naeini||McGill University|
|2014-||Lei Ding||Columbia University|
|2014-||Molly Hammell *||Cold Spring Harbor Laboratory|
|2014-||Sebastian Klinge||The Rockefeller University|
|2014-||Zachary Knight||University of California, San Francisco|
|2014-||Gregory Scherrer||Stanford University|
|2014-||Lin Tian||University of California, Davis|
|2014-||Tuan Trang||University of Calgary|
|2015-||Minoree Kohwi||Columbia University|
|2015-||Yevgenia Kozorovitskiy||Northwestern University|
|2015-||Julie Law||Salk Institute for Biological Studies|
|2015-||John Schoggins *||The University of Texas Southwestern Medical Center|
|2015-||Robert Sorge||The University of Alabama at Birmingham|
|2015-||Jeremy Wilusz||Perelman School of Medicine at the University of Pennsylvania|
|2015-||Yi Ye||New York University|
|*Milton E. Cassel Scholar|
What is the Rita Allen Foundation Scholars program? What are its funding priorities?
The Rita Allen Foundation Scholars program supports basic biomedical research in the fields of cancer, immunology and neuroscience. There also is currently a joint award for scholars in pain research, which is sponsored by the Rita Allen Foundation and the American Pain Society. Learn more about the Rita Allen Foundation Award in Pain here.
The Rita Allen Foundation Scholars program has supported more than 140 scientists since 1976. The program embraces innovative research with above-average risk and groundbreaking possibilities. Scholars have gone on to win the Nobel Prize in Physiology or Medicine, the National Medal of Science, the Wolf Prize in Medicine and the Breakthrough Prize in Life Sciences.
What size of grants are available to Rita Allen Foundation Scholars?
Scholars can receive up to $110,000 per year for a maximum of five years. Scholars in Pain Research can be granted $50,000 per year for up to three years.
What can the grant funds be used for?
Rita Allen Foundation Scholar grant funds may only be used for direct project expenses, including up to 50 percent of the Scholar’s compensation.
Who is eligible to apply for the Scholars program?
Only invited institutions are eligible to submit a nomination for consideration for the Rita Allen Foundation Scholars program. The Rita Allen Foundation Scientific Advisory Committee reviews and recommends eligible institutions, which are confirmed by the Rita Allen Foundation Board of Directors.
The Scientific Advisory Committee reviews and selects finalists from the eligible institutions for the Scholars program.
Only one nominated candidate per eligible institution is accepted per year.
If an institution is not on the eligible list, how can it be considered for inclusion?
Institutions not currently eligible but interested should write to Elizabeth Good Christopherson, President and Chief Executive Officer, Rita Allen Foundation, 92 Nassau Street, Third Floor, Princeton, New Jersey 08542. The Rita Allen Foundation will notify institutions deemed eligible to nominate. The Scientific Advisory Committee typically reviews the eligibility list in the spring of each year with invitation letters released in the summer or early fall.
Who is eligible to become a Rita Allen Foundation Scholar?
To be eligible for a Rita Allen Foundation Scholars Award, candidates must be nominated by a selected institution and have completed their training and provided persuasive evidence of distinguished achievement or extraordinary promise in research in one of the relevant fields (cancer, immunology, neuroscience or pain).
Who should be nominated for the Rita Allen Foundation Scholars program?
Institutions should consider the following when considering who to nominate for the Rita Allen Foundation Scholars program:
Applicants with committed awards that overlap the first two years of the Rita Allen Foundation Scholars Program from the Beckman Young Investigator Program, Kimmel Scholar Award, Pew Scholars Program in Biomedical Sciences, and Searle Scholars Program are not eligible. Other sources of funding may influence selection.
Nominating institutions should consider the highly competitive nature of the Rita Allen Foundation Scholars program and submit their strongest nominee for consideration. The Rita Allen Foundation requests that eligible institutions share with us a description of the process they follow to nominate candidates.
Further questions regarding the Rita Allen Foundation Scholars program should be directed to those responsible for the internal nominating process within a given eligible institution.
What are the key dates and deadlines for the 2016 program?
|November 2, 2015 through January 22, 2016||Application period|
|December 11, 2015||Letter of Inquiry (LOI) deadline|
|January 22, 2016||Proposal deadline|
|February and March 2016||Review period|
|April 28, 2016||Finalist interviews - New York City|
|May 2016||Grant awards announced|
|June 2016||Grant contracts due|
|July 2016||Press announcement|
|September 2016 – August 2021||Grant period|
|August 31, 2017, 2018, 2019, 2020||Interim reports due|
|December 1, 2021||Final report due|
What is the nomination and application process?
The nomination must be completed by a senior official at the nominating institution and must be completed online through Fluxx, a Web-based grant application system. Nominations should include the following required support materials:
Institutions are limited to submitting one nomination per review cycle.
Once the nomination is complete and has been approved by the Foundation, candidates are required to complete the grant application in Fluxx and provide the following application support materials:
What reports are required of Rita Allen Foundation Scholars?
Successful grant recipients are required to provide complete narrative and financial reports detailing their expenditure of the grant funds and progress made toward the goal(s) of the grants. Grant reports also must be submitted online through Fluxx.